Suppr超能文献

抗白细胞介素-2受体抗体(达利珠单抗)在肝细胞异种移植实验模型中的有益作用。

Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation.

作者信息

Papagoras Dimitrios, Papalois Apostolos, Tsaroucha Alexandra, Lytras Dimitrios, Kyriazanos John, Giannakou Nikoletta, Laftsidis Prodromos, Simopoulos Constantine

机构信息

2nd Department of Surgery, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.

出版信息

World J Gastroenterol. 2007 Mar 7;13(9):1435-7. doi: 10.3748/wjg.v13.i9.1435.

Abstract

AIM

To investigate the use of Daclizumab (Dmab) as an immunosuppressive agent in an experimental model of hepatocyte xenotransplantation (XenoTx) in rats with fulminant hepatic failure (FHF).

METHODS

Two white male New Zealand rabbits were used as donors and 68 Wistar rats as recipients. FHF was induced by intravenous application of dimethylnitrosamine (DMNA). The isolated hepatocytes of the rabbits were xenotransplanted into the spleen of the rats 24 h after FHF induction. Group A (n = 13): no treatment; Group B (n = 14): FHF and XenoTx; Group C (n = 14): FHF and XenoTx and cyclosporin (CsA); Group D (n = 14): FHF and XenoTx and Dmab; Group E (n = 13): FHF and XenoTx and CsA and Dmab. The rats were followed for 15 d.

RESULTS

Statistical analysis showed better survival among groups D (92.86%) and E (76.92%) compared to group A (all rats died after 72 h), group B (28.57%) or group C (71.43%), although the differences were not statistically significant. Biochemical evaluation of the liver enzymes and histology confirmed satisfactory function and engraftment, respectively.

CONCLUSION

This experimental model has shown the safe, effective and beneficial use of Dmab in a xenotransplantation model of rabbit hepatocytes in rats.

摘要

目的

研究达克珠单抗(Dmab)作为免疫抑制剂在暴发性肝衰竭(FHF)大鼠肝细胞异种移植(XenoTx)实验模型中的应用。

方法

以2只白色雄性新西兰兔作为供体,68只Wistar大鼠作为受体。通过静脉注射二甲基亚硝胺(DMNA)诱导FHF。在FHF诱导24小时后,将分离的兔肝细胞异种移植到大鼠脾脏中。A组(n = 13):未治疗;B组(n = 14):FHF和XenoTx;C组(n = 14):FHF和XenoTx及环孢素(CsA);D组(n = 14):FHF和XenoTx及Dmab;E组(n = 13):FHF和XenoTx及CsA和Dmab。对大鼠进行15天的随访。

结果

统计分析显示,与A组(所有大鼠在72小时后死亡)、B组(28.57%)或C组(71.43%)相比,D组(92.86%)和E组(76.92%)的生存率更高,尽管差异无统计学意义。肝酶的生化评估和组织学检查分别证实了功能和植入情况良好。

结论

该实验模型显示了Dmab在大鼠兔肝细胞异种移植模型中的安全、有效和有益应用。

相似文献

5
Immunosuppressive T-cell antibody induction for heart transplant recipients.心脏移植受者的免疫抑制性T细胞抗体诱导治疗
Cochrane Database Syst Rev. 2013 Dec 2;2013(12):CD008842. doi: 10.1002/14651858.CD008842.pub2.

引用本文的文献

本文引用的文献

3
Novel therapies in transplantation.移植领域的新型疗法。
Expert Opin Investig Drugs. 2005 Mar;14(3):295-304. doi: 10.1517/13543784.14.3.295.
5
Hepatocyte transplantation.肝细胞移植
Transplantation. 2004 May 27;77(10):1481-6. doi: 10.1097/01.tp.0000113809.53415.c2.
6
Xenotransplantation--federal regulatory considerations.
Curr Top Microbiol Immunol. 2003;278:239-51.
8
Experimental transplantation of hepatocytes in cases of toxic acute liver failure. An allograft model.
Transpl Int. 1994;7 Suppl 1:S171-4. doi: 10.1111/j.1432-2277.1994.tb01340.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验